代谢相关脂肪性肝病临床科研与疾病管理大数据共享平台

Clinical research and disease management data platform MAFLD

搜索
论文标题 作者 发表时间 发表杂志 影响因子
Targeting THR β for MASLD Treatment: Current Progression and Emerging Prospects

Li J, Chen R, Zhang J, He J, Wang Y, Li Y

2026-01

Journal of medicinal chemistry

6.8

Improvement in health-related quality of life after treatment with resmetirom in patients with the spectrum of MASLD: From early MASH to MASH cirrhosis

Zobair M YounossiFatema NaderDominic LabriolaRebecca TaubAndrei RacilaLinda HenryMaria Stepanova

2026-02

Hepatology communications

4.6

Human MASLD is a diurnal disease driven by multisystem insulin resistance and reduced insulin availability at night

Marjot T, Smith K, Westcott F, White S, Johnson E, Srnic N, Barrett A, Hall E, Gralton K, Dennis K, Miller H, Pofi R, Cobbold JFL, Richmond R, Karpe F, Blazev R, Watt MJ, Parker BL, Hodson L, Ray DW, Tomlinson JW

2026-01

Cell metabolism

30.9

Real-world evidence in metabolic dysfunction-associated steatotic liver disease (MASLD): insights, challenges, and future directions

Huei-Tyng Huang ,Michael Hewitt ,Wenhao Li ,William Alazawi 

2025-12

The Lancet regional health. Europe

13

Global Performance of Non-invasive Tests in MASLD: Insights from the G-MASLD Study

Younossi, Z. M., de Avila, L., Petta, S., Hagström, H., Kim, S. U., Nakajima, A., Crespo, J., Castera, L., Alkhouri, N., Zheng, M. H., Treeprasertsuk, S., Ananchuensook, P., Shalimar, Tsochatzis, E., Trivikrama, S. K., Balakumaran, L. K., Fan, J. G., Roberts, S. K., Alswat, K., Wong, V. W

2025-10

Hepatology (Baltimore, Md.)

15.8

Reprogramming offspring liver health: maternal indole supplementation as a preventive strategy against MASLD

Ashok Mandala,Ram Babu Undi,Rachel C Janssen,Kameron Y Sugino,Wanke Zhao,Benjamin N Nelson,April M Teague,Nikhil Y Patil,Karin Zemsky Berry,Rohan Varshney,Bryan C Bergman,Michael C Rudolph,Aditya D Joshi,Raju V S Rajala,Karen R Jonscher,Jacob E Friedman 

2025-12

EBioMedicine 

10.8

Predictors of Fibrosis, Clinical Events and Mortality in MASLD: Data from the GlobalMASLD Study

Younossi ZM, de Avila L, Petta S, Hagström H, Kim SU, Nakajima A, Crespo J, Castera L, Alkhouri N, Zheng MH, Treeprasertsuk S, Ananchuensook P, Shalimar, Tsochatzis E, Trivikrama SK, Balakumaran LK, Fan JG, Roberts SK, Alswat K, Wong VW, Yilmaz Y, Dunn W, Francque S, Cordie A, Yu ML, Ekstedt M, Goh GB, Oliveira CP, Pessoa MG, Chan WK, Fernandez MIC, Duseja A, Arab JP, Papatheodoridis G, Sebastiani G, Villela-Nogueira C, D'Ambrosio R, Lampertico P, Alnaamani K, Holleboom AG, Valsan A, Venu A, El-Kassas M, Pennisi G, Shang Y, Liu WY, Lee HW, Kobayashi T, Kakizaki S, Caussy C, Pearlman B, Iruzubieta P, Nadeem R, Cinque F, Neonaki A, Zoncapé M, Yang RX, Song SJ, Dunn N, Gadi Z, Yeh ML, The KK, Mahadeva S, Fabian LG, Almohsen A, Leite N, Pugliese N, Vessby J, Xie C, Choudhary NS, Friend E, Poca M, Kawaguchi T, Russo FP, Gadano A, Diaz LA, Singal AK, Segrestin B, Gunn N, Mauricio D, Arrese M, Fracanzani A, Lam B, Racila A, Alqahtani SA, Stepanova M

2025-11

Hepatology (Baltimore, Md.)

15.8

Best buys for metabolic dysfunction-associated steatotic liver disease and metabolic dysfunction-associated steatohepatitis: a global Delphi study

Jeffrey V Lazarus ,Leire Agirre-Garrido ,Trenton M White ,Anish K Arora ,Melina I Manolas ,Luis Antonio Diaz ,Juan Pablo Arab ,Shira Zelber-Sagi ,Naim Alkhouri ,C Wendy Spearman,Jörn M Schattenberg,Loreta A Kondili,Patrizia Carrieri,Holly F Lofton,Priya Jaisinghani,Sonal Kumar,Ajay Duseja,Mohamed El-Kassas,Hirokazu Takahasi,Debbie L Shawcross,Jonathan G Stine,Marcela Villota-Rivas,Juan Emilio Miralles-Sanchez,Silvana Pannain,Paul N Brennan,MASLD/MASH Collaborators

2025-12

The lancet. Gastroenterology & hepatology

38.6

Hepatic Insulin Resistance and Steatosis in Metabolic DysfunctionAssociated Steatotic Liver Disease: New Insights into Mechanisms and Clinical Implications

Xuan Trong Truong , Dae Ho Lee

2025-09

Diabetes & metabolism journal

8.5

Current and emerging therapeutic landscape for metabolic dysfunction-associated steatohepatitis

Wenhao Li , William Alazawi , Rohit Loomba 

2025-11

The lancet. Gastroenterology & hepatology

38.6

1 2 3 4 5 6 7 8 9 10 11 12 13